These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36588245)

  • 1. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
    Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
    Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
    Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
    Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
    Mitra S; Janweja M; Sengupta A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
    Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
    Arora R; Goel R; Khanam S; Kumar S; Shah S; Singh S; Chhabra M; Meher R; Khurana N; Sagar T; Kumar S; Garg S; Kumar J; Saxena S; Pant R
    Clin Ophthalmol; 2021; 15():3505-3514. PubMed ID: 34429582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
    Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
    Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
    Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
    Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mucormycosis and stroke: The learning curve during the second COVID-19 pandemic.
    Ramachandran D; R A; Panicker P; S J; Sathyabhama MC; Nair A; Chandran RS; George S; S C; Iype T
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106819. PubMed ID: 36495645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
    Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
    Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
    Mani S; Thirunavukkarasu A
    Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.